vehicle

patient

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA nice volume pickup going into the close.

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

drug

That’s a lot of money to invest multiple times on a promising treatment 🚀

This is the ONLY drug in HISTORY to improve cognition after 12 months.

$SAVA A safe drug that impacts both neurodegeneration and neuroinflammation is going to have potential treating other CNS diseases.

Proper stock and proper drug doesn&#39;t smell like a scam.

Deeply appreciative of the treatment that SAVA is working to deliver,

I’m holding long term because I truly believe this is the first effective Alz treatment to date.

Xeris Biopharma Holdings Inc

manipulation

$XERS  This stock has become totally distorted by Wall Street manipulators!

In fact its just market manipulation by  shorts and rich assholes who use stocks like slot machines.

$XERS This stock is heavily MANIPULATED by a &quot;Gang of Shortsellers&quot; and has nothing to do with a fair market price!

It is so obvious this is being systematically walked down (manipulated) and has nothing to do with the Company itself, products, or the overall market.

Just goes to show how badly manipulated this is.

The manipulation of these criminals is unbelievable.

This Share Price is still 
 
Crazy  
 
Stupid  
 
Low. Cheers!

$XERS  This share price is crazy stupid low.

You’d think Paul would have some shame being below their price.

What is most disappointing about XERS, except for the collapse in stock price, is the failure of management to do much of anything to encourage retail or institutional investors to continue to have the confidence in management of the company or its future.

I think price targets are fake… there compensated to make targets IMO.

suck

Unfortunately, the mkt sucks now and that’s reflected in sp.

The whole market sucks and this has been unjustly hammered.

$XERS this is so fucked up its unbelievable.

Invested a lot of money , and realizing we are fucked.

market

What a crappy market! Hopefully next week will be better:)

$XERS A bad market must admit it is really a bad day.

$XERS A 10+ cent drop when you only have 14 of those until 0 ahead of all that gobbledygook fundamental longs are spouting is not a great sign of market confidence.

$XERS market on a year and this lame duck is flat or sinking

but unfortunately, in this market, not cheap either, and even less an outright buy without a very very strong conviction.

Market hinting something is terribly wrong with this company.

revenue

$XERS High risk is an understatement with XERS, weak drug lineup, weak pipeline, revenue grow slowing, cash burn increasing and worse than weak management should tell you to stay away.

Nothing positive, revenue continues to slow, spending increasing, generics coming, recorlev under performing and most important, incompetent management! !

Personally, I think this is very conservative, and comes in below the Strongbridge &quot;Low Case&quot; from page 87 of the merger prospectus because it comes out to $172M annual revenue in 2023 compared to $216M revenue on the prospectus.

Revenues are slowing, expenses are increasing, tech is marginal, patents will be expiring, pipeline is horrible and management is horrible.

but also very disappointing that my EV charger stocks have $Billion mkt caps with less than $50M revenue and years from cash flow positive and yet.

Not only are the current drugs low revenue producers and the pipeline is horrible.

.WS not impressed with 3 low revenue drugs and weak pipeline.

$XERS On Gvoke, &quot;better than expected growth&quot;:   
&quot;Opportunity remains huge, and you don&#39;t have to find patients.

QoQ growth would still increase by ~40% with no new patients.

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Two other drugs, each growing revenue steadily.

That said, I fully expect continuing  script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

Two (2) other drugs, each growing revenue steadily.

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

A levothyroxine formulation that looks positive (most commonly prescribed drug) A full proven technology platform to deliver hard to administer drugs by a simple injection.

We have other amazing drugs, Recorlev, Gvoke and more including some drugs yet to be approved.

product

$XERS their primary product increases 9% week to week sales with an overall trend that&#39;s incredible.

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren&#39;t acquired so they can keep a focus on that.

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

More important is that they grow Recorlev&#39;s revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Revenue exploding on the upside with
their 4 products.

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Gvoke is the best and easiest product out there.

Products have been approved and much more is coming, wait and relax.

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

NIO Inc - ADR

average

Every one of them had a above average short and Dark Pool volume.

$NIO - this is trading under the 8 Moving Average (something I do not like)

$NIO dollar average you are as negative as a crack addict and your posts on nio over the last week or more are all wrong.

$NIO I bought more to get down the average and still i am in ~50% loss

$NIO  
Average down chaps if you can, this is not going to get any better for a while.

Bunch of pussy low life’s that make and lose more money on average.

High price target $70 Average price of $37!!!

Gaps or walls .. it’s all bs….. stock is cheap as feck.

Show em what you got, filled that gap .. never lookin back.

but of course, the gaps are not what they have told you they are!

$NIO what a joke, all it did was close the gap on the top.

$NIO time to takeoff after gap fill, hate that were down

.dont pay this price, this was pumped way too high..Gaps fill 98 percent of the time and Pumpers know it.

$NIO 11.09 avg we are fucked this gap fills to 10.30

If only they could fill the gap between their ears…

power

Just ridiculous with this news tesla should be hammerd and nio up because tesla is afraid of the competition just manipulated as fuck the market is with Biden as president all the power is with the FED and just some stupid people they can fuck off

$NIO Tesla has the worst battery power loss after testing in cold weather.

How much insider trading goes on with the corrupt people in power.

This is insanity and reinforce the point that &quot;China will never be a super power, they are too busy trying to control their own population, who they have 100% control over, They can&#39;t rule the world&quot; Pathetic China and CCP.

One mistake can ruin your business especially when you piss off the politicians in power and majority of your customers (likely 90% are liberals).

They had no problem being friends with China and others in their day, it’s such a shame to see the power hungry sadsacks we have in charge of us today trying to beat the rest of the world in submission,

$NIO with Xi Jinping in power, all chinese stocks should be avoided unfortunately including now ev stock.

Xi’s power move punishes Chinese stocks, pushing them down as much as 26% in one day https://www.billionaireclubcollc.com/xis-power-move-punishes-chinese-stocks-pushing-them-down-as-much-as-26-in-one-day/  $BABA $NIO $XPEV $LI $BIDU. ..

cost

Li Bin is the give away king, operational costs and R&amp;D are excessive.

Li Bin must drive cost down and increase operational performance.

$NIO looking at normalised income statement - the problem is declining gross margins (only 14% - $LI at 20%) and high R&amp;D costs.

1) swap station cost
2) battery inventory cost
3) dead battery absorption cost
4) fast charging remove the original reason for a swap station.

They cause double costs and at best represent a transition.

$NIO with negative eps, diluting of shares, twice as much debt as equity, increasing operating cost, 5 times price to book, china risks, why the hell would anyone expect this to double in price in less than one quarter??

Firstly by making them unaffordable compared to ICE, and secondly making them unprofitable due to high input costs and inability to raise prices due to cheaper ICE alternatives.

The cost of the car is also very expensive.

But,  as it turns out autopilot has too problems, and add too much overhead to the final cost of the car.

Fuck it bought the dippppp app in 🔥🔥🔥🔥

No the desktop app for Stocktwits is down, this is the end! !

$NIO Comments in the Nio App are all very disappointed that car is just per subscription and priced very high…

$NIO I never felt this poor after watching the prices on the nio app

$NIO Judging by the insurance, 9k deliveries in March would be a fantastic result.

$NIO $XPEV $LI $LCID  lifted ,parts to make the vehicles to reach demand, and battery 🔋 cost 💲 down !

Electric automaker Polestar today revealed its third product — a sleek, sporty SUV with up to 517 horsepower and a targeted range of 300 miles […]”

But least deliveries are showing growth. .

“This electric sedan has an innovative battery swap concept, and the car gives a good first impression in terms of driving characteristics and technology.”

$NIO incredible fundamentals excellent delivery numbers!

You don’t have to worry about degrading batteries or the cost to replace them
 - If and when better battery technology is available it can easily be adapted to the NIO vehicle
3.

It is also a repair center for vehicles participating in online hailing services, and provides integrated auto services such as EV sales and after-sale maintenance.

$NIO SEEING GREEN NEXT WEEK AS DELIVERIES ARE INCREASING THROUGHOUT THE MONTH AS CONSUMERS ARE TRENDING TOWARD NIO BRAND.

They will change how AML Is treated, there phase 3 trials wre a home run.

$NIO Do not miss this $$$$

Sellas Life Sciences SLS increasing lives of cancer patients by 400% when treated with drug Gps.

$NIO best ev company stoutest treated stock

Ford will be among top EV growers for the next several years.

NIO is the most admired EV brand in the world (fact) and will profitable before Tesla or Lucid produce a new platform, function or beat NIO in range

$NIO being NIO cars will very obviously hold their value a whole lot better and no battery degradation. .

I think they might actually succeed to be 1 of the top evs in the coming years.

$MULN and all other EV tickers today $TSLA $RIVN $NIO thank you Elon

$NIO ES8 is the hottest EV in Norway among all NT 2.0 models.

The best thing to do right now is buy and hold and squeeze the shorts hard!

We alerted the BUY signal at $8.14 and we were able to close this one with profit at $8.75 🎯

$NIO Buy now and get at least 20X in 10 years or less 🌤👍

Adding in what I feel is one of the BEST BUYS Anywhere out there..jmho

.Easily one of the Best Buys anywhere in the Market here in my opinion

$NIO This will be worth a buy at $5 for a run back up to $8.

bull

$NIO $XPEV $LI LET THE BULL MARKET BEGIN.

$NIO no fear bull time let’s go 9 🚀🔥🔥🔥🔥

SPREAD THIS WINNING STRATEGY AND LETS WIN THIS ONCE AND FOR ALL BULLS

$NIO the bulls is what we want to see!! opportunities!!!

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 17, 2023

Mar, 10, 2023

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Divihomes is Now Live

NIO

NIO Inc - ADR

-15.11%

$10.92 - $9.27

Mar, 21, 2023

Mar, 21, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 17, 2023

Mar, 10, 2023

Oct, 29, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

NIO

NIO Inc - ADR

-15.11%

$10.92 - $9.27

Mar, 21, 2023

Mar, 21, 2023

Mar, 20, 2023

Mar, 19, 2023

Mar, 17, 2023

Mar, 17, 2023

Mar, 16, 2023

Mar, 15, 2023

Mar, 14, 2023

Mar, 11, 2023